Literature DB >> 16229059

Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.

Beathe Sitter1, Steinar Lundgren, Tone F Bathen, Jostein Halgunset, Hans E Fjosne, Ingrid S Gribbestad.   

Abstract

Breast cancer is the most frequent form of cancer in women and improved diagnostic methods are desirable. Malignant cells have altered metabolism and metabolic mapping might become a tool in cancer diagnostics. High-resolution magic angle spinning (HR MAS) MR spectroscopy of tissue biopsies provides detailed information on metabolic composition. The 600 MHz 1H HR MAS spectra were acquired of breast cancer tissue from 85 patients and adjacent non-involved tissue from 18 of these patients. Tissue specimens were investigated by microscopy after MR analysis. The resulting spectra were examined by three different approaches. Relative intensities of glycerophosphocholine (GPC), phosphocholine (PC) and choline were compared for cancerous and non-involved specimens. Eight metabolites, choline, creatine, beta-glucose, GPC, glycine, myo-inositol, PC and taurine, were quantified from the recorded spectra and compared with tumor histological type and size, patient's lymph node status and tissue composition of sample. The spectra were also compared with tumor histological type and size, lymph node status and tissue composition of samples using principal component analysis (PCA). Tumor samples could be distinguished from non-involved samples (82% sensitivity, 100% specificity) based on relative intensities of signals from GPC, PC and choline in 1H HR MAS spectra. Tissue concentrations of metabolites showed few differences between groups of samples, which can be caused by limitations in the quantification procedure. Choline and glycine concentrations were found to be significantly higher in tumors larger than 2 cm compared with smaller tumors. PCA of MAS spectra from patients with invasive ductal carcinomas indicated a possible prediction of spread to axillary lymph nodes. Metabolite estimates and PCA of MAS spectra were influenced by the percentage of tumor cells in the investigated specimens. 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16229059     DOI: 10.1002/nbm.992

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  85 in total

1.  Assessing hepatic metabolic changes during progressive colonization of germ-free mouse by 1H NMR spectroscopy.

Authors:  Peter Heath; Sandrine Paule Claus
Journal:  J Vis Exp       Date:  2011-12-15       Impact factor: 1.355

2.  Short-term temperature effect on the HRMAS spectra of human brain tumor biopsies and their pattern recognition analysis.

Authors:  Daniel Valverde-Saubí; Ana Paula Candiota; Maria Antònia Molins; Miguel Feliz; Oscar Godino; Myriam Dávila; Juan José Acebes; Carles Arús
Journal:  MAGMA       Date:  2010-06-13       Impact factor: 2.310

3.  High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues.

Authors:  Olaf Beckonert; Muireann Coen; Hector C Keun; Yulan Wang; Timothy M D Ebbels; Elaine Holmes; John C Lindon; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2010-05-13       Impact factor: 13.491

Review 4.  Applications of metabolomics to study cancer metabolism.

Authors:  Akash K Kaushik; Ralph J DeBerardinis
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-04-25       Impact factor: 10.680

Review 5.  Biochemical characterization of breast tumors by in vivo and in vitro magnetic resonance spectroscopy (MRS).

Authors:  Uma Sharma; Naranamangalam R Jagannathan
Journal:  Biophys Rev       Date:  2009-01-17

6.  Evaluation of the ERETIC method as an improved quantitative reference for 1H HR-MAS spectroscopy of prostate tissue.

Authors:  Mark J Albers; Thomas N Butler; Iman Rahwa; Nguyen Bao; Kayvan R Keshari; Mark G Swanson; John Kurhanewicz
Journal:  Magn Reson Med       Date:  2009-03       Impact factor: 4.668

7.  Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.

Authors:  Mayur Gadiya; Noriko Mori; Maria D Cao; Yelena Mironchik; Samata Kakkad; Ingrid S Gribbestad; Kristine Glunde; Balaji Krishnamachary; Zaver M Bhujwalla
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

Review 8.  Clinical applications of metabolomics in oncology: a review.

Authors:  Jennifer L Spratlin; Natalie J Serkova; S Gail Eckhardt
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

9.  Evaluation of Tissue Metabolites with High Resolution Magic Angle Spinning MR Spectroscopy Human Prostate Samples After Three-Year Storage at -80 degrees C.

Authors:  Kate W Jordan; Wenlei He; Elkan F Halpern; Chin-Lee Wu; Leo L Cheng
Journal:  Biomark Insights       Date:  2007-04-18

10.  Can metabolomics in addition to genomics add to prognostic and predictive information in breast cancer?

Authors:  Anthony Howell
Journal:  BMC Med       Date:  2010-11-16       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.